Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Vesicare approved as first drug for overactive bladder in Japan

April 21, 2006

Novel agents for urological disorders disclosed in recent patent literature

April 20, 2006

Pfizer to acquire rights to fesoterodine for overactive bladder

April 20, 2006

Targeting the mTOR pathway -- a promising therapeutic approach in polycystic kidney disease

April 19, 2006

Celecoxib investigated in acute renal colic

April 10, 2006

Novel tachykinin NK1 antagonists prepared and tested by Takeda

April 7, 2006

MediciNova begins phase I study for urinary incontinence treatment MN-246

April 4, 2006

Phase III hepatorenal syndrome study of terlipressin completes enrollment

March 27, 2006

Enrollment completed in second phase III study of Sanctura XR

March 24, 2006

Enrollment completed in phase II study of TH-070 for BPH

March 23, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...